INSIDER · CIK 2022156
Yeleswaram Krishnaswamy
Chief Development Officer at Rapport Therapeutics, Inc. (RAPP)
↗2 Form 4 rows in the window
Covers original filings from Aug 1, 2026 to Oct 29, 2026. Older trades and amendments are in the SEC history.
$0.00Bought on the market
$2.6MSold on the market
1Companies
Aug 26, 2026Latest filing
| Company | Title | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 26, 202616:00 | Aug 25, 2026from Aug 24, 2026 | RAPPRapport Therapeutics, Inc. | Chief Development Officer | S · Sell10b5-1 | $50.47 | −50,160 | 195,862 | -20% | −$2.5M | ||
| Aug 20, 202616:09 | Aug 19, 2026 | RAPPRapport Therapeutics, Inc. | Chief Development Officer | S · Sell10b5-1 | $49.90 | −404 | 246,022 | -0% | −$20K |